Track the 박셀바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 박셀바이오 has published 37 insider filings. Market capitalisation: €94.3bn. The latest transaction was reported on 27 March 2026 (Purchase). Among the most active insiders: 이제중. Every trade is free.
37
Insider Decl.
n/a
Thresholds
€4,477
19 ops.
Buy Volume
n/a
5 ops.
Sell Volume
31Σ signal
Buys €4,477n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.